Midday nappers have lower blood pressure levels and take fewer medications Research examining the lifestyle habits of hypertensive patients in Greece has suggested that taking a nap can improve blood pressure.…
Sacubitril/valsartan combination fast-tracked to heart failure patients A drug to reduce the risk of cardiovascular mortality and morbidity in adults with heart failure and reduced ejection fraction is being fast-tracked to patients under the UK’s Early Access to Medicines Scheme.…
UK launch for cholesterol-lowering PCSK9 inhibitor An injectable treatment has been launched for people who struggle to control their cholesterol levels through established diet and drug regimes, including patients with the genetic lipid disorder familial hypercholesterolaemia.…
Scientists get closer to finding out why statins cause muscle pain Chemical conversion of statins could disrupt muscle mitochondria function, leading to pain and weakness.…
Researchers boost hypertension treatment using unconventional approach Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.…
Target six high-risk drugs during medication reviews, say researchers Researchers have identified six high-risk medicines or combinations of high-risk medicines that should be targeted in medicines reviews to reduce iatrogenic disease in older people.…
Heart risks with newer hepatitis C drugs and amiodarone The EMA has warned against the use of antiarrhythmic amiodarone in combination with newer hepatitis C infection treatments after reports of heart problems.…
Metformin plays a role in lowering blood cholesterol Metformin, one of the most widely used medications for type 2 diabetes, has a positive effect on LDL cholesterol as well as blood glucose, according to research published in Diabetes Care.…
Preclinical randomised controlled trials could tackle high attrition rates in drug development Researchers have come up with a potential solution to the problem of experimental drugs failing in clinical trials, despite promising results from preclinical, animal studies.…
MHRA review concludes alteplase is safe for treating acute ischaemic stroke The Medicines and Healthcare products Regulatory Agency has backed the continued use of the thrombolytic drug alteplase for up to 4.5 hours after the onset of symptoms of acute ischaemic stroke.…
